Inulin ameliorates chronic ketamine-induced anxiety-like behaviors and impairments in spatial learning and memory: involvement of gut microbiota, microbial metabolite short-chain fatty acids, and the BDNF-TrkB-ERK1/2-CREB pathway.

Overview

1. Institute of Neuropsychiatry, The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China
2. Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders, Guangzhou, China
3. Department of Psychosomatic Medicine, The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China

Abstract

Chronic ketamine exposure results in psychotic and cognitive symptoms that resemble those found in patients with schizophrenia. Emerging evidence suggests that patients with schizophrenia exhibit gut microbiota dysbiosis and decreased levels of short-chain fatty acids (SCFAs) and BDNF, which are related to the severity of psychotic and cognitive symptoms. Dietary inulin can regulate gut microbiota, SCFAs, and BDNF. However, the role of gut microbiota, SCFAs, and BDNF in chronic ketamine-induced schizophrenia-like behaviors is unclear. In this study, we found that chronic ketamine exposure for 28 days caused gut microbiota dysregulation, reduced the expression of SCFAs in serum, hippocampus, and feces, elevated gut permeability, downregulated the BDNF-TrkB-ERK1/2-CREB signaling pathway, caused neuronal damage, and decreased the expression of synaptic proteins Syn and PSD-95, which may lead to anxiety-like behaviors, prepulse inhibition (PPI) deficits, and spatial learning and memory deficits. In addition, inulin intervention reversed gut microbiota dysbiosis by decreasing the abundance of Colidextribacter, Oscillibacter, Alistipes, and Desulfovibrio, while increasing the abundance of Lachnospiraceae_NK4A136_group, Faecalibaculum, and Blautia. It also increased the expression of SCFAs, alleviated gut barrier damage, and upregulated the BDNF-TrkB-ERK1/2-CREB signaling pathway to reduce neuronal damage and enhance the expression of Syn and PSD-95, which may improve chronic ketamine-induced anxiety-like behaviors, PPI impairments, and spatial learning and memory deficits. Our findings provide additional evidence that inulin may be a promising candidate for treating chronic ketamine-associated anxiety-like behaviors and deficits in spatial learning and memory, as well as behavioral deficits in schizophrenia with dysbiosis.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data, not to its authors' code: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

• bioproject:PRJNA1437400, at NCBI BioProject; found in “Data availability statement”

Data availability statement

The data presented in the study are deposited in the National Center for Biotechnology Information (NCBI) repository, accession number: PRJNA1437400, https://www.ncbi.nlm.nih.gov/sra/PRJNA1437400.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 29 September 2026: the first record

Recorded: type, language, journal, volume, pages, dates, 4 authors, 6 keywords, 73 references.

Cite

This paper

Xu, Z., Zhang, J., Hu, C., & Luo, Y. (2026). Inulin ameliorates chronic ketamine-induced anxiety-like behaviors and impairments in spatial learning and memory: involvement of gut microbiota, microbial metabolite short-chain fatty acids, and the BDNF-TrkB-ERK1/2-CREB pathway. Frontiers in microbiology, 17, 1765079. https://doi.org/10.3389/fmicb.2026.1765079

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1038/s41398-026-03965-z [code]

Disentangling individual heterogeneity reveals robust network and molecular signatures of major depressive disorder with suicidal ideation.

Journal: Translational psychiatry

In common: cellular / molecular, 3 references

[2] doi:10.3389/fmicb.2026.1811435

Research on the role of gut microbiota metabolites in autism by multi-omics and network pharmacology.

Journal: Frontiers in microbiology

In common: 2 references

[3] doi:10.1007/s00406-026-02302-1 [code]

Exploring the genetic correlation between inflammatory bowel disease and psychiatric disorders: insights from genome-wide association studies.

Journal: European archives of psychiatry and clinical neuroscience

In common: other condition, cellular / molecular, 1 reference

[4] doi:10.1038/s41398-026-04142-y [code]

Phocaeicola vulgatus improves anxiety-like behavior by ameliorating amygdala neuroinflammation and the neurite impairment in IBS.

Journal: Translational psychiatry

In common: other condition, 1 reference

[5] doi:10.1002/advs.202519889 [code]

Functional Mapping of Neurodevelopmental Disease Pathways to Key Neurodevelopmental Processes Represented in the Developmental Neurotoxicity In Vitro Testing Battery.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

In common: other condition, 1 reference

[6] doi:10.3389/fmicb.2026.1889475

<i>Lactobacillus acidophilus</i> CICC 22162 alleviates sleep deprivation-induced cognitive impairment by remodeling gut microbiota and enhancing S-adenosylmethionine-mediated neuroimmune regulation.

Journal: Frontiers in microbiology

In common: cellular / molecular, 1 reference

[7] doi:10.21203/rs.3.rs-9474472/v1 [code]

Donor Microbiota Metabolic Capacity Determines Engraftment Dynamics and Modulates Gut–Brain Signaling in Recipient Mice

Journal: Research Square (preprint)

In common: cellular / molecular, 1 reference

[8] doi:10.3389/fphar.2026.1790866

Akkermansia muciniphila improving depression-like behaviors by regulating glycerophospholipid metabolism in gut-brain axis.

Journal: Frontiers in pharmacology

In common: cellular / molecular, 1 reference

[9] doi:10.1371/journal.pone.0353463 [code]

Distinct gut and oral microbiome patterns associated with dyslexia in a family-based cohort: A preliminary exploratory study.

Journal: PloS one

In common: other condition, 1 reference

[10] doi:10.1038/s12276-026-01739-7

Targeting the SIRT6-TDO2/KYNA-mTOR axis rescues synaptic and cognitive deficits in fetal growth restriction offspring.

Journal: Experimental & molecular medicine

In common: cellular / molecular, 1 reference

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.